
Sewage & the city: Ahead of monsoon, open drain near condo raises a stink
Noida: The open sewer drain in front of
La Solara Apartments
near Ek Murti Chowk in Sector 16 has turned into a breeding ground for mosquitoes, raising serious health concerns for over 2,500 residents. With the monsoon season approaching, the clogged and waste-filled drain has become a major civic hazard, residents alleged.
"The drain has not been cleaned for months. It's filled with muck and plastic waste. The mosquito menace is worsening every day," said Darryll Gonsalves, a resident of La Solara apartments.
Adding to the problem, Gonsalves claimed that dirty water from the adjacent Casa Green society continuously flows onto the road outside, creating a perennial water hole. "It remains waterlogged throughout the year," he added.
La Solara apartments, spread over 1.85 acres, comprises four towers with 670 residential units and houses more than 2,500 people. The area also includes several other high-rises like KA Divya Towers, RG Luxury Homes, and Panchsheel Greens 2, collectively accommodating over 10,000 residents.
Despite being well connected to nearby landmarks such as Gulshan Belina Road, Mahagun Marina Walk and Kaith Hospital, Sector 16 continues to grapple with poor civic management and sanitation issues.
Residents also complained about weekly market encroachments that worsen the hygiene situation. "On Wednesdays and Sundays, the market opposite our society leaves behind rotting fruits, vegetables, and plastic waste, much of which ends up in the nallah beside the service road," said another resident.
Local residents said that repeated complaints to the Greater Noida Industrial Development Authority (GNIDA) have gone unheeded. Besides sanitation issues, concerns were also raised regarding inadequate street lighting and lack of security in the area.
Officials from the authority said the concerns of residents will be looked into.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
17 minutes ago
- Reuters
European shares recover in broader gains; trade uncertainty persists
June 3 (Reuters) - European shares rebounded on Tuesday amid broader gains, while investors continued to monitor any developments on the U.S. trade policy front. The pan-European STOXX 600 (.STOXX), opens new tab index was up 0.2% as of 0707 GMT, after kicking off June on a slightly lower note. Some optimism remained after the White House said that Trump and his Chinese counterpart will likely speak this week, amid escalating trade tensions, even as investors remained cautious about the future of U.S. President Donald Trump's erratic tariffs. The Trump administration asked an appeals court to pause a second court ruling that had brought up legal hurdles for the duties, while pushing countries for their best trade offers by Wednesday. Euro zone inflation numbers are scheduled to be released on Tuesday, ahead of the European Central Bank's interest rate decision this week. UBS (UBSG.S), opens new tab gained 3.3% after Jefferies upgraded the bank's stock to "buy" from "hold". Julius Baer (BAER.S), opens new tab slipped 1.9%. The Swiss bank announced further cost-saving measures amounting to 130 million Swiss franc ($159.02 million) by 2028.
Yahoo
18 minutes ago
- Yahoo
Biomarker Data from Alligator Bioscience's OPTIMIZE-1 Trial Presented at ASCO 2025 Annual Meeting
LUND, SE / / June 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that biomarker data from its OPTIMIZE-1 clinical trial were presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. OPTIMIZE-1 is a Phase 1b/2 trial evaluating mitazalimab in combination with mFOLFIRINOX in first-line metastatic pancreatic cancer (mPDAC). The study has demonstrated strong clinical outcomes to date, including a ~30% survival rate at 24 months and a median overall survival of 14.9 months. The biomarker analyses highlighted mitazalimab's immunological mechanism of action, with immune activation in responding patients and gene signatures associated with clinical benefit and improved survival. These results support continued development of mitazalimab, including a planned confirmatory trial in mPDAC. "ASCO continues to be a cornerstone event for clinical oncology, and it was a privilege to share our OPTIMIZE-1 data with the international community," said Søren Bregenholt, CEO of Alligator Bioscience. "The high level of engagement and many productive meetings we've had during the conference further validate the growing interest in mitazalimab and its potential in pancreatic cancer." The presentation poster is available on Alligator's website . Alligator's participation at ASCO is part of its broader commitment to scientific collaboration and strategic business development. For further information, please contact: Søren Bregenholt, CEOE-mail: +46 (0) 46 540 82 00 The information was submitted for publication, through the agency of the contact person set out above, at 8:45 a.m. CEST on 3 June 2025. About Alligator Bioscience Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. This validated approach promotes priming of tumor-specific T cells and reversing the immunosuppressive nature of the tumor microenvironment, with significant potential benefits for cancer patients across multiple types of cancer. The Company's lead drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 24-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1. Alligator is listed on Nasdaq Stockholm (ATORX) and headquartered in Lund, Sweden. For more information, please visit . Attachments Biomarker data from Alligator Bioscience's OPTIMIZE-1 trial presented at ASCO 2025 Annual Meeting SOURCE: Alligator Bioscience View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


9 News
19 minutes ago
- 9 News
Fresh search launched over disappearance of Madeleine McCann
Police are carrying out new searches for missing British girl Madeleine McCann 18 years after she disappeared from a Portuguese holiday resort.